Patent details

EP3092256 Title: COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

Basic Information

Publication number:
EP3092256
PCT Application Number:
CN2015070379
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157348491
PCT Publication Number:
WO2015103989
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
French Title of Invention:
COMPOSÉS ET COMPOSITIONS POUR L'IMMUNOTHÉRAPIE
German Title of Invention:
VERBINDUNGEN UND ZUSAMMENSETZUNGEN FÜR DIE IMMUNTHERAPIE
SPC Number:

Dates

Filing date:
08/01/2015
Grant date:
18/05/2022
EP Publication Date:
16/11/2016
PCT Publication Date:
16/07/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/05/2022
EP B1 Publication Date:
18/05/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/01/2023
Expiration date:
08/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/05/2022
 
 

Name:
Birdie Biopharmaceuticals Inc.
Address:
Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman, Cayman Islands (KY)

Inventor

Name:
LI, Lixin
Address:
China (CN)

Priority

1

Priority Number:
201410011362
Priority Date:
10/01/2014
Priority Country:
China (CN)

2

Priority Number:
201410011262
Priority Date:
10/01/2014
Priority Country:
China (CN)

3

Priority Number:
201410011324
Priority Date:
10/01/2014
Priority Country:
China (CN)

Classification

IPC classification:
C07K 16/32; A61K 31/4745; A61K 31/522; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
202220
Publication date:
18/05/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages